ST. MICHAELS MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $3.3M
- Transactions
- 423
- Companies
- 26
- Average per transaction
- $7,763
Who reported the payments
| Viiv Healthcare Company | $1,248,506 |
| Janssen Research & Development, LLC | $670,032 |
| Gilead | $573,475 |
| Theratechnologies Inc. | $194,181 |
| Merck | $156,272 |
| AbbVie | $128,005 |
| Amgen | $61,380 |
| Novartis | $58,169 |
| Surmodics, Inc. | $38,965 |
| American Regent | $36,770 |
| CSL Behring | $34,369 |
| Hoffmann-la Roche Limited | $26,567 |
| Biotronik Inc. | $24,449 |
| Johnson & Johnson | $9,590 |
| Novo Nordisk AS | $5,223 |
| Angiodynamics, Inc. | $3,731 |
| Mindray DS USA, Inc. | $3,665 |
| Aesculap, Inc. | $2,992 |
| Biotest AG | $2,500 |
| Fisher Scientific Company L.L.C. | $2,044 |
| AstraZeneca | $1,475 |
| Arrow International, Inc. | $646 |
| Olympus America Inc. | $435 |
| Merit Medical Systems Inc | $223 |
| Stryker | $129 |
| Zimmer Biomet | $71 |